English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis Journal article
Ge, Pu, Han, Chunyan, Reyila, Abudurousuli, Liu, Diyue, Hong, Wenying, Liu, Jiaxin, Zhang, Jinzi, Han, Xiao, Li, Xialei, Huang, Mengjie, Fan, Siyuan, Kaierdebieke, Ayidana, Wu, Xiaoyu, Huang, Xiaolu, Guo, Weirui, Liu, Siyu, Bian, Ying. Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis[J]. Medicine, 2023, 102(35), e34793.
Authors:  Ge, Pu;  Han, Chunyan;  Reyila, Abudurousuli;  Liu, Diyue;  Hong, Wenying; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:1.3/1.6 | Submit date：2023/09/12
Adverse Events  Aflibercept  Antiangiogenesis  Meta-analysis  Metastatic Colorectal Cancer  Safety  Systematic Review  
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment Review article
2022
Authors:  Ge, Pu;  Wan, Ning;  Han, Xiao;  Wang, Xinpei;  Zhang, Jinzi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:1  IF:4.4/5.0 | Submit date：2023/01/30
Aflibercept  Cost-effectiveness Analysis  Metastatic Colorectal Cancer  Pharmacoeconomics  Rapid Health Technology Assessment  Targeted Drugs